These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36316781)

  • 1. Comment on "The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis".
    Minamino H; Torii M; Katsushima M; Fujita Y; Hashimoto M
    Arthritis Res Ther; 2022 Nov; 24(1):245. PubMed ID: 36316781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis.
    Hein TR; Peterson L; Bartikoski BJ; Portes J; Espírito Santo RC; Xavier RM
    Arthritis Res Ther; 2022 Jul; 24(1):171. PubMed ID: 35854372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic and targeted synthetic disease-modifying anti-rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease-modifying anti-rheumatic drugs: Results from the PRESENT study.
    Tada M; Matsumoto Y; Koike T; Mamoto K; Nakamura T; Anno S; Iida T; Goto H; Hidaka N
    Int J Rheum Dis; 2024 Oct; 27(10):e15371. PubMed ID: 39381837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis.
    Ben Tekaya A; Mehmli T; Ben Sassi M; Teyeb Z; Bouden S; Rouached L; Mahmoud I; Dziri C; Abdelmoula L
    Clin Rheumatol; 2023 Apr; 42(4):979-997. PubMed ID: 36462127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in skeletal muscle mass is associated with lipid profiles in female rheumatoid arthritis patients -TOMORROW study.
    Matsumoto Y; Sugioka Y; Tada M; Okano T; Mamoto K; Inui K; Habu D; Koike T
    Clin Nutr; 2021 Jun; 40(6):4500-4506. PubMed ID: 33413913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Comment on "The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis".
    Hein TR; Peterson L; Bartikoski BJ; Portes J; Espirito Santo RC; Xavier RM
    Arthritis Res Ther; 2022 Nov; 24(1):246. PubMed ID: 36320079
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    de Souza MPGUES; Guimarães NS; de Resende Guimarães MFB; de Souza VA; Kakehasi AM
    Adv Rheumatol; 2022 May; 62(1):16. PubMed ID: 35606888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.
    Choy EH; Smith C; Doré CJ; Scott DL
    Rheumatology (Oxford); 2005 Nov; 44(11):1414-21. PubMed ID: 16030080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of skeletal muscle mass in patients with rheumatic diseases under glucocorticoid therapy--comparison among bioelectrical impedance analysis, computed tomography, and magnetic resonance imaging.
    Hosono O; Yoshikawa N; Shimizu N; Kiryu S; Uehara M; Kobayashi H; Matsumiya R; Kuribara A; Maruyama T; Tanaka H
    Mod Rheumatol; 2015 Mar; 25(2):257-63. PubMed ID: 25496410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle disease in rheumatoid arthritis: the center of cardiometabolic comorbidities?
    Andonian BJ; Huffman KM
    Curr Opin Rheumatol; 2020 May; 32(3):297-306. PubMed ID: 32141950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of anti-rheumatic agents on the periodontal condition of patients with rheumatoid arthritis and periodontitis: A systematic review and meta-analysis.
    Zhang J; Xu C; Gao L; Zhang D; Li C; Liu J
    J Periodontal Res; 2021 Dec; 56(6):1099-1115. PubMed ID: 34514591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.
    Engvall IL; Tengstrand B; Brismar K; Hafström I
    Arthritis Res Ther; 2010; 12(5):R197. PubMed ID: 20964833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle Deficits in Rheumatoid Arthritis Contribute to Inferior Cortical Bone Structure and Trabecular Bone Mineral Density.
    Baker JF; Long J; Mostoufi-Moab S; Denburg M; Jorgenson E; Sharma P; Zemel BS; Taratuta E; Ibrahim S; Leonard MB
    J Rheumatol; 2017 Dec; 44(12):1777-1785. PubMed ID: 28916544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.
    Graudal N; Hubeck-Graudal T; Tarp S; Christensen R; Jürgens G
    PLoS One; 2014; 9(9):e106408. PubMed ID: 25244021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of muscle mass assessed by dual-energy X-ray absorptiometry and bioelectrical impedance analysis in older patients with heart failure.
    Saito H; Matsue Y; Maeda D; Kasai T; Kagiyama N; Endo Y; Zoda M; Mizukami A; Yoshioka K; Hashimoto T; Ishikawa K; Minamino T
    Geriatr Gerontol Int; 2022 Aug; 22(8):610-615. PubMed ID: 35751442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which is the best alternative to estimate muscle mass for sarcopenia diagnosis when DXA is unavailable?
    Sousa-Santos AR; Barros D; Montanha TL; Carvalho J; Amaral TF
    Arch Gerontol Geriatr; 2021; 97():104517. PubMed ID: 34547538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    Geriatr Gerontol Int; 2019 Sep; 19(9):907-912. PubMed ID: 31342647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of skeletal muscle mass by bioimpedance and differences among skeletal muscle mass indices for assessing sarcopenia.
    Xu HQ; Liu JM; Zhang X; Xue YT; Shi JP; Chen W; Zheng XY
    Clin Nutr; 2021 Apr; 40(4):2308-2318. PubMed ID: 33121834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Syngle A; Kaur S; Verma I; Syngle T; Syngle V
    Clin Rheumatol; 2017 Aug; 36(8):1715-1720. PubMed ID: 28634699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.